In the last trading session, 1.48 million CRISPR Therapeutics AG (NASDAQ:CRSP) shares changed hands as the company’s beta touched 1.76. With the company’s per share
In last trading session, CRISPR Therapeutics AG (NASDAQ:CRSP) saw 1.4 million shares changing hands with its beta currently measuring 1.75. Company’s recent per share price
In today’s recent session, 0.73 million shares of the CRISPR Therapeutics AG (NASDAQ:CRSP) have been traded, and its beta is 1.81. Most recently the company’s
In the last trading session, 1.26 million CRISPR Therapeutics AG (NASDAQ:CRSP) shares changed hands as the company’s beta touched 1.87. With the company’s per share
CRISPR Therapeutics AG (NASDAQ:CRSP) has a beta value of 1.71 and has seen 0.52 million shares traded in the recent trading session. The company, currently
CRISPR Therapeutics AG (NASDAQ: CRSP) expects to submit an application for gene therapy approval by the end of the year. This medicine already earned good
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne